Gilead Sciences logo

VP, Development IT

Gilead Sciences

Foster City, CAOnsitePosted 2 days ago
Full TimeDirector & AboveTech & Data (Health IT)Pharmaceutical
Original posting ↗

Summary

We are seeking a visionary and results-driven VP, Development IT to serve as a senior strategic partner to our Development organization. In this role, you will be the primary technical thought partner for our Chief Medical Office and his leadership team, guide investment decisions on core platforms and AI, and deliver on enterprise priorities tied to pipeline advancement and patient impact.

Job description

You will be accountable for the vision, strategy, and outcomes of technology, data, and AI capabilities that fuel Gilead's innovation pipeline, drive long-term growth and improve global health. Operating with a product owner mindset, you will define and drive integrated IT strategies and long-term roadmaps that align business and technology priorities to enable scientific advancement across drug discovery, development, and regulatory execution.

This is a highly visible, executive-facing role with shared ownership of scientific portfolio outcomes, and accelerating assets and therapies from the lab bench to market. As a senior IT leader, you will be accountable for portfolio performance, value realization and disciplined investment management, balancing innovation, speed, compliance and cost in a highly regulated environment. You will drive enterprise impact through the application of advanced analytics and AI/ML, enabling data-driven scientific decision-making and accelerating time to market.

This position will report directly to the CIO, lead a global D IT organization, and is based at our corporate headquarters in Foster City, California. Moderate travel (25%) is required to engage global stakeholders and team.

Major Responsibilities

  • Establish and Drive Strategic Portfolio: Build and deliver integrated scientific and Development data, analytics and platform strategies and ensuring scalability and interoperability across research informatics (ELN, LIMS), clinical, regulatory and data ecosystems. Manage technology investments and ensure every initiative delivers value in terms of ROI, pipeline acceleration and enterprise strategy alignment.
  • Balance Business and Technology Needs: Act as trusted advisor to executives, translating scientific priorities into scalable, compliant digital solutions and co-owning technology-enabled outcomes.
  • End-to-End Accountability: Own the technology vision and joint business/IT prioritization decisions. Serve as decision-maker on technology choices, MVP scope, investment priorities and long-term roadmap direction.
  • Executive Alignment and Governance: Establish shared accountability with executives and IT stakeholders and represent the Development digital product portfolio in governance bodies such as steering committees, investment reviews, and operational councils. Establish governance frameworks that ensure data integrity, validation, and regulatory compliance (e.g., GxP).
  • Trade-Offs and Decision-Making: Navigate cross-functional tensions (e.g., speed vs compliance, innovation vs cost containment), facilitate transparent and equitable decisions across multiple business domains and enable transparent, data-driven decisions.
  • Business Transformation Leadership: Partner with functional leadership to drive transformation initiatives leveraging data, advanced analytics, and AI/ML to accelerate the scientific lifecycle.
  • Vendor and Partner Management: Build and maintain strong, mutually-beneficial relationships with external partners, vendors and industry consortia, representing Gilead in relevant innovation and technology forums.
  • Team Leadership: Lead and grow IT teams of employees and contract services fostering agile, product-oriented delivery and a culture of innovation, accountability and continuous improvement while building future-ready capabilities.

Key Skills & Experiences

  • 15+ years of progressive leadership experience in IT business partnership and leadership roles, preferably in a regulated life sciences environment.
  • Bachelor's degree in Life Sciences, Business or Information Technology. Masters or PhD preferred.
  • Deep understanding of drug discovery, development, regulatory processes and scientific workflows within the biopharmaceutical industry.
  • Proven track record of owning large, complex technology portfolios with accountability for strategy, investment decisions and value realization.
  • Able to translate scientific and business needs into robust technology solutions.
  • Demonstrated success in leading scientific AI/ML initiatives from strategy through execution.
  • Skilled in Agile, scrum or SAFe frameworks and techniques and able to translate voice-of-customer insights into product features and investments.
  • Recognized expert in R&D technology ecosystems including ELN, LIMS, and clinical and regulatory systems as well as cloud and digital platforms.
  • Strong knowledge of regulatory, quality, validation and risk management frameworks, including GxP, data integrity and compliance requirements, including HIPAA.
  • Strong executive presence with the ability to engage and influence C-level stakeholders.
  • Exceptional stakeholder management and collaboration skills within highly-matrixed, global organizations.
  • Proven ability to inspire, build and lead high-performing teams, developing leadership talent and fostering an inclusive, outcome-driven culture.
  • Strong financial literacy, with proven track record building business cases, ROI modeling and technology spend optimization as well as linking IT investments to measurable pipeline acceleration, speed-to-market and asset differentiation.
  • Excellent oral and written communication skills, including the ability to explain technology solutions in business terms, establish rapport and persuade others.
  • Experience leading enterprise-scale digital and AI transformation initiatives in regulated, high-complexity environments.

Requirements

  • 15+ years of progressive leadership experience in IT business partnership and leadership roles, preferably in a regulated life sciences environment
  • Bachelor's degree in Life Sciences, Business or Information Technology
  • Deep understanding of drug discovery, development, regulatory processes and scientific workflows within the biopharmaceutical industry
  • Proven track record of owning large, complex technology portfolios with accountability for strategy, investment decisions and value realization
  • Able to translate scientific and business needs into robust technology solutions
  • Demonstrated success in leading scientific AI/ML initiatives from strategy through execution
  • Skilled in Agile, scrum or SAFe frameworks and techniques
  • Recognized expert in R&D technology ecosystems including ELN, LIMS, and clinical and regulatory systems as well as cloud and digital platforms
  • Strong knowledge of regulatory, quality, validation and risk management frameworks, including GxP, data integrity and compliance requirements, including HIPAA
  • Strong executive presence with the ability to engage and influence C-level stakeholders
  • Exceptional stakeholder management and collaboration skills within highly-matrixed, global organizations
  • Proven ability to inspire, build and lead high-performing teams
  • Strong financial literacy, with proven track record building business cases, ROI modeling and technology spend optimization
  • Excellent oral and written communication skills
  • Experience leading enterprise-scale digital and AI transformation initiatives in regulated, high-complexity environments

Company overview

Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.